(NASDAQ: SGHT) Sight Sciences's forecast annual revenue growth rate of 9.44% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.63%.
Sight Sciences's revenue in 2024 is $81,056,000.On average, 4 Wall Street analysts forecast SGHT's revenue for 2024 to be $4,104,753,487, with the lowest SGHT revenue forecast at $4,038,104,203, and the highest SGHT revenue forecast at $4,199,697,746. On average, 4 Wall Street analysts forecast SGHT's revenue for 2025 to be $4,700,285,899, with the lowest SGHT revenue forecast at $4,524,222,772, and the highest SGHT revenue forecast at $4,880,115,083.
In 2026, SGHT is forecast to generate $5,680,947,112 in revenue, with the lowest revenue forecast at $5,599,035,389 and the highest revenue forecast at $5,762,908,387.